Vertex Reports First-Quarter 2021 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Dow tick higher as investors weigh Mideast negotiations
- Oil falls after US-Iran talks signal easing supply risks
- Intel soars after Trump says Apple agreed to work with chipmaker on US production
- Apple CEO warns price hikes 'unavoidable' as chip costs bite - WSJ
- Wall Street scrambles to lift Micron price targets ahead of earnings
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- China makes small dent in deflation battle as supply-demand imbalance persists
- Sanuwave cuts Q2 2026 revenue guidance amid Ultramist sales pressure
Vertex Pharma (VRTX) Tops Q1 EPS by 29c, Revenues Beat
April 29, 2021 4:08 PM EDTVertex Pharma (NASDAQ: VRTX) reported Q1 EPS of $2.98, $0.29 better than the analyst estimate of $2.69. Revenue for the quarter came in at $1.72 billion versus the consensus estimate of $1.66 billion.
"In CF, our goal is that all eligible patients have access to and can... More
